Dr. Sujit Itty , MD
Ophthalmology • Phoenix, AZ
1101 E Missouri Ave
Phoenix, AZ 850142709
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 17, 2009; this date does not establish years in practice.
-
Published CMS data list 165,548 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 — Injection, faricimab-svoa, 0.1 mg: 140,401 service units.
- Q5128 — Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg: 5,160 service units.
- 92134 — Imaging of retina: 4,770 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 27 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 882 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate — 273 prescription fills, including refills.
- Moxifloxacin (Moxifloxacin Hcl) — 142 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) — 124 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 16 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Phoenix, AZ (2024, 58 clinicians with data). Median for this group: 1,821. Middle half: 431 to 3,617.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Arizona (2024, 224 clinicians with data). Median for this group: 2,115. Middle half: 1,040 to 3,509.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 17,849 in 2020 to 165,548 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1101 E Missouri Ave
Phoenix, AZ 850142709
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Flagstaff, AZ. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Retinal Consultants Of Arizona Ltd. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Mayo Medical School
2009
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,852 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $9,657,025 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $7,603,317 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,245 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$35,521 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,064.52 across 36 records.
By nature of payment
- Food and Beverage: $1,064.52 across 36 records.
Reporting-company totals (3 largest of 9)
- Regeneron Pharmaceuticals, Inc.: $319.65 across 9 records.
- Genentech, Inc.: $204.50 across 7 records.
- Apellis Pharmaceuticals, Inc.: $158.89 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
17 years (graduated 2009)
CMS Doctors and Clinicians data list 2009 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2009
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Itty has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Itty as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Phoenix and Arizona
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Phoenix, AZ (2024, 58 clinicians with data). Median for this group: 1,821. Middle half: 431 to 3,617.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Arizona (2024, 224 clinicians with data). Median for this group: 2,115. Middle half: 1,040 to 3,509.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Phoenix, AZ (2024, 58 clinicians with data). Median for this group: $229,661. Middle half: $70,262 to $513,268.
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Arizona (2024, 224 clinicians with data). Median for this group: $256,049. Middle half: $132,587 to $448,948.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Phoenix, AZ (2024, 58 clinicians with data). Median for this group: $159,769. Middle half: $50,320 to $401,714.
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Arizona (2024, 224 clinicians with data). Median for this group: $189,644. Middle half: $91,683 to $334,260.
Medicare Part D prescriptions
More Part D prescriptions than 60% of clinicians listed under Ophthalmology in Phoenix, AZ (2024, 61 clinicians with data). Median for this group: 736. Middle half: 292 to 1,389.
Close to the middle for clinicians listed under Ophthalmology in Arizona (2024, 231 clinicians with data). Median for this group: 825. Middle half: 320 to 1,750.
Part D drug cost
Close to the middle for clinicians listed under Ophthalmology in Phoenix, AZ (2024, 61 clinicians with data). Median for this group: $41,761. Middle half: $8,503 to $111,048.
Close to the middle for clinicians listed under Ophthalmology in Arizona (2024, 231 clinicians with data). Median for this group: $54,057. Middle half: $10,893 to $153,679.
92 active clinicians are listed under Ophthalmology with a practice address in Phoenix, AZ (353 in Arizona).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Phoenix
0% of these 92 clinicians have the CMS telehealth indicator.
62% of these 92 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 827% from 17,849 in 2020 to 165,548 in 2024.
- 2020: 17,849
- 2021: 20,467
- 2022: 28,778
- 2023: 101,923
- 2024: 165,548
-
Medicare-allowed amount
Medicare-allowed amount increased 103% from $4,765,725 in 2020 to $9,657,025 in 2024.
- 2020: $4,765,725
- 2021: $5,351,679
- 2022: $5,748,796
- 2023: $7,879,800
- 2024: $9,657,025
-
Paid by Medicare
Paid by Medicare increased 102% from $3,764,778 in 2020 to $7,603,317 in 2024.
- 2020: $3,764,778
- 2021: $4,243,290
- 2022: $4,504,385
- 2023: $6,207,888
- 2024: $7,603,317
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 59% from 556 in 2020 to 882 in 2024.
- 2020: 556
- 2021: 812
- 2022: 793
- 2023: 754
- 2024: 882
-
30-day fills
30-day fills increased 70% from 731 in 2020 to 1,245 in 2024.
- 2020: 731
- 2021: 1,090
- 2022: 1,085
- 2023: 1,089
- 2024: 1,245
-
Part D drug cost
Part D drug cost increased 29% from $27,593 in 2020 to $35,521 in 2024.
- 2020: $27,593
- 2021: $27,198
- 2022: $28,260
- 2023: $24,112
- 2024: $35,521
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $425.42 in 2021 to $1,064.52 in 2025.
- 2021: $425.42
- 2022: $6,842.41
- 2023: $1,734.94
- 2024: $3,046.13
- 2025: $1,064.52
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 36 records totaling $1,064.52.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
Syfovre | General | $149.22 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $39.84 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $39.41 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $37.84 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $37.19 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $36.05 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $35.93 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $34.84 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $34.32 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $33.60 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $33.58 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $33.04 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $32.74 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $32.33 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $29.74 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $29.39 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $27.46 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $26.12 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $25.38 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $24.95 |
| Harrow Eye, LLC |
Food and Beverage
In-kind items and services
|
IHEEZO | General | $23.58 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $21.91 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
XIPERE | General | $21.90 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $21.49 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $21.26 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
140,401 | 396 | $95.24 | $34.53 |
|
Q5128
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
|
5,160 | 258 | $721.00 | $230.91 |
|
92134
Imaging of retina
|
4,770 | 1,818 | $104.98 | $40.78 |
|
67028
Injection of drug into eye
|
3,609 | 940 | $345.54 | $134.50 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,802 | 1,160 | $270.00 | $129.74 |
|
J2781
Injection, pegcetacoplan, intravitreal, 1 mg
|
1,635 | 27 | $376.00 | $146.78 |
|
J2782
Injection, avacincaptad pegol, 0.1 mg
|
1,440 | 18 | $270.00 | $108.37 |
|
J0178
Injection, aflibercept, 1 mg
|
1,318 | 206 | $2325.00 | $828.25 |
|
J3299
Injection, triamcinolone acetonide (xipere), 1 mg
|
1,232 | 17 | $115.25 | $47.77 |
|
J0177
Injection, aflibercept hd, 1 mg
|
1,224 | 50 | $855.00 | $330.31 |
|
92014
Established patient complete exam of visual system
|
1,047 | 789 | $315.00 | $126.74 |
|
J7312
Injection, dexamethasone, intravitreal implant, 0.1 mg
|
574 | 36 | $500.00 | $202.31 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
367 | 367 | $410.00 | $169.27 |
|
J7314
Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
|
234 | 11 | $1230.00 | $519.01 |
|
J7999
Compounded drug, not otherwise classified
|
217 | 88 | $294.84 | $91.84 |
|
J3590
Unclassified biologics
|
126 | 83 | $6835.60 | $1408.06 |
|
92012
Established patient problem focused exam of visual system
|
105 | 89 | $220.00 | $90.05 |
|
92235
Exam of retinal blood vessels using a special camera after injection of a dye
|
66 | 65 | $260.00 | $165.19 |
|
67145
Photocoagulation treatment to prevent detachment of retina
|
48 | 45 | $1369.79 | $247.37 |
|
67042
Removal of membrane of retina with removal of internal limiting membrane of retina
|
32 | 32 | $2870.00 | $1151.54 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
32 | 32 | $520.00 | $223.47 |
|
67516
Injection of drug into the space between the cornea and retina in the eye
|
28 | 15 | $300.36 | $121.61 |
|
67113
Complex repair of detached retina and drainage of eye fluid between lens and retina
|
19 | 16 | $3335.00 | $1265.66 |
|
67039
Destruction of eye fluid (vitreous) between lens and retina using a laser
|
16 | 13 | $2400.00 | $963.40 |
|
76512
2d ultrasound scan of eye tissue and structures
|
16 | 15 | $215.00 | $48.58 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 273 | 7,282 | $9,340.92 | 168 |
| Moxifloxacin | Moxifloxacin Hcl | 142 | 2,228 | $4,533.99 | 91 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 124 | 9,436 | $2,145.82 | 56 |
| Brimonidine Tartrate | Brimonidine Tartrate | 63 | 2,830 | $1,064.53 | 25 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 47 | 1,904 | $1,318.89 | 16 |
| Ofloxacin | Ofloxacin | 37 | 723 | $378.29 | 33 |
| Timolol Maleate | Timolol Maleate | 34 | 1,605 | $182.03 | 16 |
| Dorzolamide Hcl | Dorzolamide Hcl | 26 | 1,235 | $178.65 | — |
| Valacyclovir | Valacyclovir Hcl | 20 | 751 | $462.20 | — |
| Atropine Sulfate | Atropine Sulfate | 19 | 732 | $820.09 | — |
| Loteprednol Etabonate | Loteprednol Etabonate | 19 | 574 | $2,672.98 | — |
| Latanoprost | Latanoprost | 17 | 870 | $152.70 | — |
| Lumigan | Bimatoprost | 17 | 580 | $6,993.89 | — |
| Erythromycin | Erythromycin Base | 17 | 170 | $215.52 | — |
| Bromfenac Sodium | Bromfenac Sodium | 14 | 391 | $3,936.52 | — |
| Difluprednate | Difluprednate | 13 | 319 | $1,124.04 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-01-26NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20151031000006
AZ
2769620442
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Retinal Consultants Of Arizona Ltd
1101 E Missouri Ave, Phoenix, AZ 850142709
Phone: 8006406442
Secondary Practice Locations
350 N Switzer Canyon Dr
Flagstaff, AZ 860014826
Phone: 0295510006
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 4800 N 22ND ST STE 210, PHOENIX, AZ 850164963 (Tel: 6029776190)
Ophthalmology (license number reported to NPPES: AZ 51210)
NPI status registered as active in NPPES database
Registered at 1101 E MISSOURI AVE, PHOENIX, AZ 850142709 (Tel: 6022222221)
Registered at PO BOX 32530, PHOENIX, AZ 850642530 (Tel: 6022222221)
Recorded as SUJIT ITTY, MD
Ophthalmology (license number reported to NPPES: AZ 51210)
NPI status registered as active in NPPES database
Registered at 1101 E MISSOURI AVE, PHOENIX, AZ 850142709 (Tel: 6022222221)
Registered at PO BOX 32530, PHOENIX, AZ 850642530 (Tel: 6022222221)
Recorded as SUJIT ITTY, MD
Ophthalmology (license number reported to NPPES: AZ 51210)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Phoenix
- Dr. Andrew Mohammed, MD
- Dr. Scott Sonne, MD
- Dr. Andrew Wallmann, MD
- Dr. Richard Isenberg, MD
- Dr. Robert Bullington, MD
- Dr. Leslie Kanda, MD
Mailing Address
4800 N 22nd St Ste 210
Phoenix, AZ 850164963
Phone: 6029776190